Evolent Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolent Health and other ETFs, options, and stocks.

About EVH

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. 

CEO
Seth B. Blackley
CEOSeth B. Blackley
Employees
4,200
Employees4,200
Headquarters
Arlington, Virginia
HeadquartersArlington, Virginia
Founded
2011
Founded2011
Employees
4,200
Employees4,200

EVH Key Statistics

Market cap
642.27M
Market cap642.27M
Price-Earnings ratio
-1.20
Price-Earnings ratio-1.20
Dividend yield
Dividend yield
Average volume
2.81M
Average volume2.81M
High today
$5.82
High today$5.82
Low today
$5.48
Low today$5.48
Open price
$5.76
Open price$5.76
Volume
3.57M
Volume3.57M
52 Week high
$12.07
52 Week high$12.07
52 Week low
$2.10
52 Week low$2.10

Stock Snapshot

Evolent Health(EVH) stock is priced at $5.65, giving the company a market capitalization of 642.27M. It carries a P/E multiple of -1.20.

As of 2026-07-05, Evolent Health(EVH) stock has fluctuated between $5.48 and $5.82. The current price stands at $5.65, placing the stock +3.2% above today's low and -2.9% off the high.

The Evolent Health(EVH)'s current trading volume is 3.57M, compared to an average daily volume of 2.81M.

In the last year, Evolent Health(EVH) shares hit a 52-week high of $12.07 and a 52-week low of $2.10.

In the last year, Evolent Health(EVH) shares hit a 52-week high of $12.07 and a 52-week low of $2.10.

EVH News

Investing.com 23h
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com

...

Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com
TipRanks 5d
Evolent Health downgraded to Hold from Buy at Truist

Truist downgraded Evolent Health (EVH) to Hold from Buy with an unchanged price target of $7. The company’s 2027 consensus EBITDA estimates do not fully reflect...

Analyst ratings

79%

of 14 ratings
Buy
78.6%
Hold
21.4%
Sell
0%

People also own

Based on the portfolios of people who own EVH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.